Morrison Foerster advised 9am.health in the completion of its $16 million Series A financing round. 9am.health is a virtual diabetes clinic that offers personalized and affordable care directly to consumers. The company will use the new funding to scale its clinical and pharmaceutical services to include more medications, to integrate additional medical devices, and to expand platform partners nationwide.
The round was co-led by 7Wire Ventures and Human Capital and included participation from existing investors Define Ventures and Founders Fund. Read more.
